Opinion
Video
Author(s):
Dr. Latanya Benjamin, MD, FAAD, FAAP, continues her discussion on a 35-year-old female patient with vitiligo by analyzing laboratory workup results and exploring advanced treatment decisions to optimize patient outcomes.
Upadacitinib Shows Biomarker-Driven Efficacy in Nonsegmental Vitiligo
The Cutaneous Connection: Enhancing Vitiligo Care With Nanette Silverberg, MD
Vitiligo in Clinical Practice: Expert Insights on Diagnosis, Comorbidities, and Treatment
ReV Up Your Vitiligo Treatment Strategies
Patients with DIMIDs and Pandemic Risks
Topical TCA and Methoxsalen Not Clinically Effective for Acral Vitiligo